FDA Inspection 1000607 — Loyola University Chicago Health Sciences Campus IRB
The FDA completed an inspection of Loyola University Chicago Health Sciences Campus IRB on January 28, 2016 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 28, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maywood, IL (United States)
Additional Details
IRB